Product Name |
Almotriptan D6 Maleate |
Alternate Names |
Almotriptan Stable Isotopes, Stable Isotopes of Almotriptan |
CAT No. |
CS-O-03184
|
CAS No. |
1020764-56-0(Freebase) |
Category |
Stable Isotopes |
Stock |
IN-Stock
|
Mol. Wt. |
457.57 g/mol |
Mol. For. |
C₂₁H₂₃D₆N₃O₆S
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Almotriptan |
Therapeutic |
Anti-Migraines |
Smileys |
O=[S](CC1=CC=C2C(C(CCN(C([2H])([2H])[2H])C([2H])([2H])[2H])=CN2)=C1)(N3CCCC3)=O.OC(/C=C\C(O)=O)=O |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Almotriptan D6 Maleate is a pharmaceutical drug that is used to treat migraines. It is a selective serotonin receptor agonist that works by narrowing blood vessels in the brain and reducing the release of chemicals that cause inflammation. The D6 in the name refers to the presence of six deuterium atoms in the molecular structure, which are used as tracers in clinical studies to measure the drug's absorption, distribution, metabolism, and excretion in the body.
The maleate salt form of almotriptan is used to enhance its solubility and stability in water-based formulations. It is available in tablet form for oral administration, with a recommended dose of 12.5 mg per day. The drug is rapidly absorbed after ingestion, with a peak plasma concentration reached within 1-3 hours. It is metabolized in the liver and excreted in the urine, with a half-life of about 3-4 hours.
Almotriptan D6 Maleate is generally well tolerated, with common side effects including nausea, dizziness, fatigue, and dry mouth. It is contraindicated in patients with severe liver or kidney disease, uncontrolled hypertension, or a history of heart attack or stroke. The drug may also interact with other medications, such as antidepressants and MAO inhibitors.
Overall, almotriptan D6 maleate is a valuable tool in the management of migraines, providing fast and effective relief for many patients. Its chemical properties and pharmacokinetic profile make it a safe and reliable option for those suffering from this debilitating condition.